サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1500822

医療用マリファナ市場：世界の産業分析、規模、シェア、成長、動向、2024年～2033年予測

Medical Marijuana Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日: | 発行: Persistence Market Research | ページ情報: 英文 283 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
医療用マリファナ市場：世界の産業分析、規模、シェア、成長、動向、2024年～2033年予測
出版日: 2024年06月20日
発行: Persistence Market Research
ページ情報: 英文 283 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の医療用マリファナ市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 医療用マリファナの市場規模（2024E）：292億米ドル
  • 予測市場価値（2033F）：967億米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：14.2%

医療用マリファナ市場：調査範囲

医療用マリファナは、慢性疼痛、てんかん、多発性硬化症、化学療法による吐き気・嘔吐など、さまざまな病状の治療に使用されています。同市場は、病院、診療所、在宅介護など多様なエンドユーザーに対応し、オイル、チンキ、カプセル、エディブルなど様々な形態の医療用マリファナ製品を提供しています。市場成長の原動力は、医療用大麻の合法化と受容の拡大、慢性疾患の有病率の上昇、大麻研究の進歩による治療効果と患者の転帰の向上です。

市場成長の促進要因：

世界の医療用大麻市場は、疼痛、てんかん、多発性硬化症などの慢性疾患の治療における大麻の治療効果に対する認識の高まりなど、いくつかの主要な要因によって推進されています。医療用大麻を合法化する国の増加とそれに伴う患者数の増加が、市場拡大をさらに後押ししています。大麻の抽出と製剤化技術における技術の進歩は、製品の品質と一貫性を向上させ、市場の成長を促進します。さらに、医療従事者や患者の間で医療用大麻が受け入れられつつあることで、市場参入企業はより多くの患者層にアプローチする新たな道を切り開いています。

市場抑制要因：

有望な成長見通しにもかかわらず、医療用大麻市場は、大麻使用に関連する規制遵守、スティグマ、安全性への懸念に関する課題に直面しています。医療用大麻の栽培、加工、流通に関する厳しい規制は、生産者やヘルスケアプロバイダーにコンプライアンス上の負担を課し、市場参入障壁や運営コストに影響を与えます。さらに、大麻使用にまつわる偏見や、長期的効果に関する臨床的エビデンスが限られていることが、特に保守的な地域における市場浸透の課題となっています。こうした規制や社会的障壁に対処するには、安全で効果的な医療用大麻ソリューションへのアクセスを促進するために、業界利害関係者、政策立案者、医療界が協力する必要があります。

市場機会：

医療用マリファナ市場は、技術革新、人口動向、進化するヘルスケア提供モデルによって大きな成長機会がもたらされます。遠隔医療プラットフォームなどのデジタルヘルス技術の統合は、患者の医療用マリファナ診察へのアクセスを向上させ、治療のアドヒアランスと転帰を改善します。さらに、疼痛管理だけでなく、神経疾患、精神疾患、炎症性疾患の治療など、医療用大麻の用途が拡大していることは、市場の範囲を広げ、イノベーションを刺激します。戦略的パートナーシップ、研究開発への投資、ユーザーフレンドリーで費用対効果の高い医療用マリファナ製品のイントロダクションは、新たな機会を活用し、ダイナミックな大麻ランドスケープにおける市場のリーダーシップを維持するために不可欠です。

レポートが回答する主な質問

  • 医療用大麻市場の世界の成長を促進する主な要因は何か？
  • さまざまなヘルスケア環境で医療用大麻の普及を促進している製品タイプと用途は何か？
  • 技術の進歩は医療用マリファナ市場の競合情勢をどのように変えているか？
  • 医療用マリファナ市場に貢献している主要プレイヤーは誰で、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界の医療用マリファナ市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • 採用率/使用状況分析- 主要統計
  • サプライチェーン分析
  • 患者の治療の過程
  • 主な規制- 地域別
  • パイプライン評価
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 用途別
    • 流通チャネル別
    • 地域別
  • 2024年の市場シナリオ

第7章 世界の医療用マリファナ市場の需要分析

  • 2019年～2023年の市場金額の歴史的分析
  • 現在および将来の市場金額予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対的な$機会分析

第8章 世界の医療用マリファナ市場分析（製品別）

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、製品別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、製品別、2024年～2033年
    • ドライフラワー
    • 抽出フォーム
  • 製品別市場の魅力分析

第9章 用途別世界医療用マリファナ市場分析

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、用途別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、用途別、2024年～2033年
    • 疼痛管理
    • 発作
    • その他
  • 用途別の市場の魅力分析

第10章 流通チャネル別世界医療用マリファナ市場分析

  • イントロダクション/主な調査結果
  • 過去の市場規模分析、流通チャネル別、2019年～2023年
  • 現在および将来の市場規模の分析と予測、流通チャネル別、2024年～2033年
    • 小売薬局
    • eコマース
  • 流通チャネル別市場の魅力分析

第11章 地域別世界の医療用マリファナ市場分析

  • イントロダクション
  • 2019年～2023年における地域別市場規模の過去分析
  • 現在および将来の市場金額の分析と予測、地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第12章 北米医療用マリファナ市場分析

第13章 ラテンアメリカの医療用マリファナ市場分析

第14章 欧州の医療用マリファナ市場分析

第15章 東アジアの医療用マリファナ市場分析

第16章 南アジアの医療用マリファナ市場分析

第17章 オセアニアの医療用マリファナ市場

第18章 中東・アフリカ（中東・アフリカ）医療用マリファナ市場分析

第19章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第20章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Tilray
    • Aurora Cannabis
    • Canopy Growth Corporation
    • Aphria, Inc.
    • Maricann Group, Inc.
    • Tikun Olam, Ltd.
    • MedReleaf. Corp.
    • GW Pharmaceuticals plc.
    • Cannabis Sativa, Inc.
    • Medical Marijuana, Inc.

第21章 使用される仮定と頭字語

第22章 調査手法

目次
Product Code: PMRREP13897

Persistence Market Research has recently released a comprehensive report on the worldwide market for medical marijuana. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Medical Marijuana Market Size (2024E): USD 29.2 Billion
  • Projected Market Value (2033F): USD 96.7 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 14.2%

Medical Marijuana Market - Report Scope:

Medical marijuana is used in the treatment of various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and chemotherapy-induced nausea and vomiting. The market caters to a diverse range of end-users, including hospitals, clinics, and homecare settings, offering various forms of medical marijuana products such as oils, tinctures, capsules, and edibles. Market growth is driven by increasing legalization and acceptance of medical marijuana, rising prevalence of chronic diseases, and advancements in cannabis research, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global medical marijuana market is propelled by several key factors, including growing awareness about the therapeutic benefits of cannabis in treating chronic conditions such as pain, epilepsy, and multiple sclerosis. The increasing number of countries legalizing medical marijuana and the subsequent rise in patient populations further drive market expansion. Technological advancements in cannabis extraction and formulation techniques offer improved product quality and consistency, fostering market growth. Moreover, the expanding acceptance of medical marijuana among healthcare professionals and patients creates new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the medical marijuana market faces challenges related to regulatory compliance, stigma, and safety concerns associated with cannabis use. Stringent regulations governing the cultivation, processing, and distribution of medical marijuana impose compliance burdens on producers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, the stigma associated with marijuana use and limited clinical evidence on long-term effects pose challenges for market penetration, particularly in conservative regions. Addressing these regulatory and societal barriers requires collaboration between industry stakeholders, policymakers, and the medical community to promote access to safe and effective medical marijuana solutions.

Market Opportunities:

The medical marijuana market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as telemedicine platforms, enhances patient access to medical marijuana consultations and improves treatment adherence and outcomes. Furthermore, the expanding application of medical marijuana beyond pain management, including in the treatment of neurological disorders, mental health conditions, and inflammatory diseases, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective medical marijuana products are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic cannabis landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the medical marijuana market globally?
  • Which product types and applications are driving medical marijuana adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the medical marijuana market?
  • Who are the key players contributing to the medical marijuana market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global medical marijuana market?

Competitive Intelligence and Business Strategy:

Leading players in the global medical marijuana market, including Canopy Growth Corporation, Aurora Cannabis Inc., and GW Pharmaceuticals plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced cannabis-based therapies, including CBD oils, THC formulations, and novel delivery systems, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, medical distributors, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving cannabis landscape.

Key Companies Profiled:

  • Tilray
  • Aurora Cannabis
  • Canopy Growth Corporation
  • Aphria, Inc.
  • Maricann Group, Inc.
  • Tikun Olam, Ltd.
  • MedReleaf. Corp.
  • GW Pharmaceuticals plc.
  • Cannabis Sativa, Inc.
  • Medical Marijuana, Inc.

Key Segments Covered in Medical Marijuana Industry Research

Product:

  • Dried flower
  • Extract Form

Indication:

  • Pain Management
  • Seizure
  • Others

Distribution Channel:

  • Retail pharmacies
  • E-commerce

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - Key Statistics
  • 4.2. Supply Chain Analysis
  • 4.3. Patient Treatment Journey
  • 4.4. Key Regulations - By Region
  • 4.5. Pipeline Assessment
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Pain Management Drugs Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Number of People Suffering from Chronic Pain
    • 5.2.2. Legalization of Medical Marijuana
    • 5.2.3. Increasing Commercialization of Products
    • 5.2.4. Mergers and Acquisitions
    • 5.2.5. Regulatory Policies
    • 5.2.6. Rising Initiatives Regarding Marijuana's Health benefits
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Region
  • 6.2. 2024 Market Scenario

7. Global Medical Marijuana Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis, by Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Product, 2024-2033
    • 8.3.1. Dried flower
    • 8.3.2. Extract Form
  • 8.4. Market Attractiveness Analysis, by Product

9. Global Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Application, 2024-2033
    • 9.3.1. Pain Management
    • 9.3.2. Seizure
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by Application

10. Global Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Distribution Channel, 2024-2033
    • 10.3.1. Retail pharmacies
    • 10.3.2. E-commerce
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Bn) Analysis, by Region, 2019-2023
  • 11.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia
    • 11.3.6. Oceania
    • 11.3.7. Middle East and Africa (MEA)
  • 11.4. Market Attractiveness Analysis, by Region

12. North America Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By Distribution Channel
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping
  • 12.7. Drivers and Restraints - Impact Analysis
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Medical Marijuana Market Analysis
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By Distribution Channel
    • 12.8.2. Canada Medical Marijuana Market Analysis
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By Distribution Channel

13. Latin America Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Mexico
      • 13.3.1.2. Brazil
      • 13.3.1.3. Argentina
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Mexico Medical Marijuana Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By Distribution Channel
    • 13.8.2. Brazil Medical Marijuana Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By Distribution Channel
    • 13.8.3. Argentina Medical Marijuana Market Analysis
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By Distribution Channel

14. Europe Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Germany
      • 14.3.1.2. Italy
      • 14.3.1.3. France
      • 14.3.1.4. U.K.
      • 14.3.1.5. Spain
      • 14.3.1.6. BENELUX
      • 14.3.1.7. Russia
      • 14.3.1.8. Rest of Europe
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Germany Medical Marijuana Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Italy Medical Marijuana Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. France Medical Marijuana Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By Distribution Channel
    • 14.8.4. U.K. Medical Marijuana Market Analysis
      • 14.8.4.1. Introduction
      • 14.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.4.2.1. By Product
        • 14.8.4.2.2. By Application
        • 14.8.4.2.3. By Distribution Channel
    • 14.8.5. Spain Medical Marijuana Market Analysis
      • 14.8.5.1. Introduction
      • 14.8.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.5.2.1. By Product
        • 14.8.5.2.2. By Application
        • 14.8.5.2.3. By Distribution Channel
    • 14.8.6. BENELUX Medical Marijuana Market Analysis
      • 14.8.6.1. Introduction
      • 14.8.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.6.2.1. By Product
        • 14.8.6.2.2. By Application
        • 14.8.6.2.3. By Distribution Channel
    • 14.8.7. Russia Medical Marijuana Market Analysis
      • 14.8.7.1. Introduction
      • 14.8.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.7.2.1. By Product
        • 14.8.7.2.2. By Application
        • 14.8.7.2.3. By Distribution Channel

15. East Asia Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Distribution Channel (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Product
    • 15.4.2. By Application
    • 15.4.3. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. China Medical Marijuana Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Japan Medical Marijuana Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. South Korea Medical Marijuana Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By Distribution Channel

16. South Asia Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. India
      • 16.3.1.2. Indonesia
      • 16.3.1.3. Malaysia
      • 16.3.1.4. Thailand
      • 16.3.1.5. Rest of South Asia
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. India Medical Marijuana Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Indonesia Medical Marijuana Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. Malaysia Medical Marijuana Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. Thailand Medical Marijuana Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Application
        • 16.8.4.2.3. By Distribution Channel

17. Oceania Medical Marijuana Market 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Australia
      • 17.3.1.2. New Zealand
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By Distribution Channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Australia Medical Marijuana Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. New Zealand Medical Marijuana Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Medical Marijuana Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. GCC Countries
      • 18.3.1.2. Turkey
      • 18.3.1.3. South Africa
      • 18.3.1.4. North Africa
      • 18.3.1.5. Rest of Middle East and Africa
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. GCC Countries Medical Marijuana Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Application
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Turkey Medical Marijuana Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Application
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. South Africa Medical Marijuana Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Application
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. North Africa Medical Marijuana Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Application
        • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

  • 19.1. Market Analysis, by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Tilray
      • 20.3.1.1. Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Sales Footprint
      • 20.3.1.4. Key Financials
      • 20.3.1.5. SWOT Analysis
      • 20.3.1.6. Strategy Overview
        • 20.3.1.6.1. Marketing Strategy
        • 20.3.1.6.2. Product Strategy
        • 20.3.1.6.3. Channel Strategy
    • 20.3.2. Aurora Cannabis
      • 20.3.2.1. Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Sales Footprint
      • 20.3.2.4. Key Financials
      • 20.3.2.5. SWOT Analysis
      • 20.3.2.6. Strategy Overview
        • 20.3.2.6.1. Marketing Strategy
        • 20.3.2.6.2. Product Strategy
        • 20.3.2.6.3. Channel Strategy
    • 20.3.3. Canopy Growth Corporation
      • 20.3.3.1. Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Sales Footprint
      • 20.3.3.4. Key Financials
      • 20.3.3.5. SWOT Analysis
      • 20.3.3.6. Strategy Overview
        • 20.3.3.6.1. Marketing Strategy
        • 20.3.3.6.2. Product Strategy
        • 20.3.3.6.3. Channel Strategy
    • 20.3.4. Aphria, Inc.
      • 20.3.4.1. Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Sales Footprint
      • 20.3.4.4. Key Financials
      • 20.3.4.5. SWOT Analysis
      • 20.3.4.6. Strategy Overview
        • 20.3.4.6.1. Marketing Strategy
        • 20.3.4.6.2. Product Strategy
        • 20.3.4.6.3. Channel Strategy
    • 20.3.5. Maricann Group, Inc.
      • 20.3.5.1. Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Sales Footprint
      • 20.3.5.4. Key Financials
      • 20.3.5.5. SWOT Analysis
      • 20.3.5.6. Strategy Overview
        • 20.3.5.6.1. Marketing Strategy
        • 20.3.5.6.2. Product Strategy
        • 20.3.5.6.3. Channel Strategy
    • 20.3.6. Tikun Olam, Ltd.
      • 20.3.6.1. Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Sales Footprint
      • 20.3.6.4. Key Financials
      • 20.3.6.5. SWOT Analysis
      • 20.3.6.6. Strategy Overview
        • 20.3.6.6.1. Marketing Strategy
        • 20.3.6.6.2. Product Strategy
        • 20.3.6.6.3. Channel Strategy
    • 20.3.7. MedReleaf. Corp.
      • 20.3.7.1. Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Sales Footprint
      • 20.3.7.4. Key Financials
      • 20.3.7.5. SWOT Analysis
      • 20.3.7.6. Strategy Overview
        • 20.3.7.6.1. Marketing Strategy
        • 20.3.7.6.2. Product Strategy
        • 20.3.7.6.3. Channel Strategy
    • 20.3.8. GW Pharmaceuticals plc.
      • 20.3.8.1. Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Sales Footprint
      • 20.3.8.4. Key Financials
      • 20.3.8.5. SWOT Analysis
      • 20.3.8.6. Strategy Overview
        • 20.3.8.6.1. Marketing Strategy
        • 20.3.8.6.2. Product Strategy
        • 20.3.8.6.3. Channel Strategy
    • 20.3.9. Cannabis Sativa, Inc.
      • 20.3.9.1. Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Sales Footprint
      • 20.3.9.4. Key Financials
      • 20.3.9.5. SWOT Analysis
      • 20.3.9.6. Strategy Overview
        • 20.3.9.6.1. Marketing Strategy
        • 20.3.9.6.2. Product Strategy
        • 20.3.9.6.3. Channel Strategy
    • 20.3.10. Medical Marijuana, Inc.
      • 20.3.10.1. Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Sales Footprint
      • 20.3.10.4. Key Financials
      • 20.3.10.5. SWOT Analysis
      • 20.3.10.6. Strategy Overview
        • 20.3.10.6.1. Marketing Strategy
        • 20.3.10.6.2. Product Strategy
        • 20.3.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology